Albert Jang

26PUBLICATIONS
98CO-AUTHORS
ChemotherapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Veterinary anaesthesiology and intensive careCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Aug 01, 2026
Paclitaxel and carboplatin after disease progression on immune checkpoint inhibitor for patients with metastatic urothelial carcinoma.

|May 21, 2026
Variant allele frequency as a potential marker in response to frontline systemic therapy for patients with locally advanced and metastatic urothelial carcinoma.

|Feb 27, 2026
Recent Advances in Immunotherapy for Non-Muscle-Invasive Bladder Cancer.

Abby L Grier, Jeffrey Y Zhong, Spyridon Basourakos

|Nov 26, 2025
Superwarfarin Rodenticide Poisoning due to Consumption of Exotic Animals: A Case Report.

Batoul Sadek, Cassandra Dasmarinas, Ishita Patel

|Oct 21, 2025
Management of Renal Cell Carcinoma of Variant Histology.

Luciana Chagas Prado, Albert Jang, Milena S Tariki

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

Pageof 5

Frequent Collaborators

13 joint publications

Pedro C Barata

6 joint publications

Jason R Brown

3 joint publications

Yousef Zakharia

3 joint publications

Elisabeth I Heath